House Bill 5605
115th Congress(2017-2018)
Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act
Active
Passed House on Jun 19, 2018
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5605
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
checkPassed on June 19, 2018
Status
Passed
Type
Voice Vote
Voice Vote
A vote in which the presiding officer states the question, then asks those in favor and against to say "Yea" or "Nay," respectively, and announces the result according to his or her judgment. The names or numbers of senators voting on each side are not recorded.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5239-5241)
Summary
Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act
This bill requires the Centers for Medicare & Medicaid Services (CMS) to carry out a demonstration program to: (1) increase access of opioid use disorder treatment services for Medicare beneficiaries, (2) improve physical and mental health outcomes for such beneficiaries, and (3) reduce Medicare expenditures.
Opioid use disorder care teams of practitioners may apply for participation in the demonstration project. The CMS must establish a performance-based incentive payment for participating teams.
The CMS must adopt or develop program quality standards and performance methods.
June 20, 2018
June 19, 2018
June 12, 2018
April 24, 2018
06/20/2018
Received in the Senate and Read twice and referred to the Committee on Finance.
06/19/2018
The title of the measure was amended. Agreed to without objection.
06/19/2018
Motion to reconsider laid on the table Agreed to without objection.
06/19/2018
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5239-5241)
06/19/2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5239-5241)
06/19/2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 5605.
06/19/2018
Considered under suspension of the rules. (consideration: CR H5239-5243)
06/19/2018
Mr. Walden moved to suspend the rules and pass the bill, as amended.
06/12/2018
Placed on the Union Calendar, Calendar No. 578.
06/12/2018
Committee on Ways and Means discharged.
06/12/2018
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-744, Part I.
05/17/2018
Ordered to be Reported (Amended) by Voice Vote.
05/17/2018
Committee Consideration and Mark-up Session Held.
05/01/2018
Referred to the Subcommittee on Health.
04/24/2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
04/24/2018
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:39:48 PM